127 related articles for article (PubMed ID: 11830556)
1. A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3'-splicing site leading to retention of the fourth intron.
Ding WQ; Kuntz SM; Miller LJ
Cancer Res; 2002 Feb; 62(3):947-52. PubMed ID: 11830556
[TBL] [Abstract][Full Text] [Related]
2. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
Tange TO; Damgaard CK; Guth S; Valcárcel J; Kjems J
EMBO J; 2001 Oct; 20(20):5748-58. PubMed ID: 11598017
[TBL] [Abstract][Full Text] [Related]
3. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma.
Ding WQ; Cheng ZJ; McElhiney J; Kuntz SM; Miller LJ
Cancer Res; 2002 Sep; 62(18):5223-9. PubMed ID: 12234988
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines.
Monstein HJ; Ohlsson B; Axelson J
Scand J Gastroenterol; 2001 Jul; 36(7):738-43. PubMed ID: 11444473
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.
Weinberg DS; Ruggeri B; Barber MT; Biswas S; Miknyocki S; Waldman SA
J Clin Invest; 1997 Aug; 100(3):597-603. PubMed ID: 9239407
[TBL] [Abstract][Full Text] [Related]
8. Diversity of vertebrate splicing factor U2AF35: identification of alternatively spliced U2AF1 mRNAS.
Pacheco TR; Gomes AQ; Barbosa-Morais NL; Benes V; Ansorge W; Wollerton M; Smith CW; Valcárcel J; Carmo-Fonseca M
J Biol Chem; 2004 Jun; 279(26):27039-49. PubMed ID: 15096518
[TBL] [Abstract][Full Text] [Related]
9. Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma.
Goetze JP; Nielsen FC; Burcharth F; Rehfeld JF
Cancer; 2000 Jun; 88(11):2487-94. PubMed ID: 10861424
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the cellular and molecular mechanisms of trophic action of a misspliced form of the type B cholecystokinin receptor present in colon and pancreatic cancer.
Cheng ZJ; Harikumar KG; Ding WQ; Holicky EL; Miller LJ
Cancer Lett; 2005 May; 222(1):95-105. PubMed ID: 15837546
[TBL] [Abstract][Full Text] [Related]
11. Functional recognition of the 3' splice site AG by the splicing factor U2AF35.
Wu S; Romfo CM; Nilsen TW; Green MR
Nature; 1999 Dec; 402(6763):832-5. PubMed ID: 10617206
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the CCK-C (cancer) receptor in human pancreatic cancer.
Smith JP; Verderame MF; McLaughlin P; Martenis M; Ballard E; Zagon IS
Int J Mol Med; 2002 Dec; 10(6):689-94. PubMed ID: 12429993
[TBL] [Abstract][Full Text] [Related]
13. Structure and developmental expression of the mouse CCK-B receptor gene.
Lay JM; Jenkins C; Friis-Hansen L; Samuelson LC
Biochem Biophys Res Commun; 2000 Jun; 272(3):837-42. PubMed ID: 10860839
[TBL] [Abstract][Full Text] [Related]
14. A truncated isoform of human CCK-B/gastrin receptor generated by alternative usage of a novel exon.
Miyake A
Biochem Biophys Res Commun; 1995 Mar; 208(1):230-7. PubMed ID: 7887934
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma.
Zhou W; Povoski SP; Bell RH
Carcinogenesis; 1993 Oct; 14(10):2189-92. PubMed ID: 8222074
[TBL] [Abstract][Full Text] [Related]
16. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
17. The human gastrin/cholecystokinin receptors: type B and type C expression in colonic tumors and cell lines.
Biagini P; Monges G; Vuaroqueaux V; Parriaux D; Cantaloube JF; De Micco P
Life Sci; 1997; 61(10):1009-18. PubMed ID: 9296339
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and phylogeny of U2AF35 homologs in plants.
Wang BB; Brendel V
Plant Physiol; 2006 Feb; 140(2):624-36. PubMed ID: 16407443
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous expression of cholecystokinin and gastrin receptor in stomach and pancreatic cancer: An immunohistochemical study.
Rai R; Kim JJ; Tewari M; Shukla HS
J Cancer Res Ther; 2016; 12(1):411-6. PubMed ID: 27072272
[TBL] [Abstract][Full Text] [Related]
20. Human gastric tissues simultaneously express the classical and alternative splicing cholecystokinin-B/gastrin receptors.
Zhou J; Chen M; Zhang Q; Hu J; Wang W
Recept Channels; 2004; 10(5-6):185-8. PubMed ID: 15989082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
